Related Experiment Videos

Pulmonary vascular resistance and reactivity in children with end-stage cardiomyopathy

M L Hughes1, S Kleinert, A Keogh

  • 1Department of Cardiology, Royal Children's Hospital, Melbourne, Australia.

Insights

In children with end-stage cardiomyopathy, restrictive cardiomyopathy is linked to higher pulmonary vascular resistance. Successful heart transplantation was achieved in pediatric patients with responsive pulmonary vascular resistance.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Pulmonary Hypertension

Background:

  • End-stage cardiomyopathy (CM) in children presents complex challenges, often requiring cardiac transplantation.
  • Pulmonary vascular resistance (PVR) is a critical factor influencing outcomes in these patients.

Purpose of the Study:

  • To compare pulmonary vascular resistance (PVR) and reactivity in pediatric patients with end-stage cardiomyopathy awaiting cardiac transplantation.
  • To identify predictors of successful transplantation based on PVR characteristics.

Main Methods:

  • Retrospective analysis of 63 children with end-stage cardiomyopathy referred for cardiac transplantation.
  • Assessment of pulmonary vascular resistance index (PVRI) and its reactivity.
  • Correlation of CM diagnostic category with PVR and transplantation outcomes.

Main Results:

  • The diagnostic category of cardiomyopathy was the primary determinant of PVR.
  • Children with restrictive CM were diagnosed younger and exhibited significantly higher PVRI compared to other CM types.
  • A baseline PVRI ≤ 11.8 U·m⁻² with demonstrated reactivity predicted successful orthotopic cardiac transplantation.

Conclusions:

  • Restrictive cardiomyopathy is associated with elevated PVR in pediatric cardiac transplant candidates.
  • PVR and its reactivity are crucial parameters for selecting pediatric patients for successful heart transplantation.

Related Concept Videos